GLP 1

Apitegromab is part of a wave of drugs aiming to protect or build muscle by interfering with myostatin, the body’s natural brake on muscle growth.

Introduction The amycretin timeline can be summarized honestly in one sentence: it is years from any pharmacy, with large phase 3 trials still to…

Introduction Amycretin’s side effects, based on what early trials have reported, look like the gastrointestinal pattern familiar from the GLP-1 drug class, with nausea…

Introduction Amycretin is one of the most closely watched obesity drugs in development, and the reason is simple: it is a single molecule that…

Introduction The strange truth about alcohol and GLP-1 medications is that many patients moderate effortlessly during treatment and then struggle after, because the medication…

An air fryer is a strong fit for GLP-1 dinners because it cooks protein quickly with minimal oil and almost no cleanup.

Introduction ACA marketplace plans cover GLP-1 drugs inconsistently, so the 2027 open enrollment is your chance to compare formularies and pick a plan that…

An A1C between 5.7% and 6.4% puts you in prediabetes, and the right move depends on where in that band you sit plus your other risk factors.

Six months after reaching your goal weight is exactly when you should sit down and audit every system that got you there.